Cargando…

Targeting PRC2: RNA offers new opportunities

Detalles Bibliográficos
Autores principales: Wang, Xueyin, Davidovich, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746071/
https://www.ncbi.nlm.nih.gov/pubmed/29296169
http://dx.doi.org/10.18632/oncotarget.22715
_version_ 1783289033559900160
author Wang, Xueyin
Davidovich, Chen
author_facet Wang, Xueyin
Davidovich, Chen
author_sort Wang, Xueyin
collection PubMed
description
format Online
Article
Text
id pubmed-5746071
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-57460712018-01-02 Targeting PRC2: RNA offers new opportunities Wang, Xueyin Davidovich, Chen Oncotarget Editorial Impact Journals LLC 2017-11-27 /pmc/articles/PMC5746071/ /pubmed/29296169 http://dx.doi.org/10.18632/oncotarget.22715 Text en Copyright: © 2017 Wang and Davidovich http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (http://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Editorial
Wang, Xueyin
Davidovich, Chen
Targeting PRC2: RNA offers new opportunities
title Targeting PRC2: RNA offers new opportunities
title_full Targeting PRC2: RNA offers new opportunities
title_fullStr Targeting PRC2: RNA offers new opportunities
title_full_unstemmed Targeting PRC2: RNA offers new opportunities
title_short Targeting PRC2: RNA offers new opportunities
title_sort targeting prc2: rna offers new opportunities
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746071/
https://www.ncbi.nlm.nih.gov/pubmed/29296169
http://dx.doi.org/10.18632/oncotarget.22715
work_keys_str_mv AT wangxueyin targetingprc2rnaoffersnewopportunities
AT davidovichchen targetingprc2rnaoffersnewopportunities